Affiliation: The Henry M. Jackson Foundation for the Advancement of the Military Medicine, Inc. and The Uniformed Services University of the Health Sciences

Dr. Jariwala is an Assistant Professor with the Regenerative Rehabilitation Medical Research Program, Department of Physical Medicine and Rehabilitation, at Uniformed Services University of the Health Sciences (USUHS) and is responsible for leading, planning, and conducting biomedical research and development in support of a portfolio of projects in regenerative medicine that includes neuro-regeneration, orthopedic tissue repair, biomaterials design, 3D printing and 3D bioprinting. Her group develops therapies that combine physical rehabilitation and regenerative medicine to treat service-related injuries. One of her major research thrusts is in the use of 3D bioprinting to create tissue scaffolds that can be used to enhance the natural repair of damaged tissues. Dr. Jariwala graduated in Biomedical Engineering and obtained her M.S. in 2009 and Ph.D. in 2013 from Syracuse University, where she led efforts in development and characterization of novel acrylic two-solution bone cements for treatment of spinal compression fractures. As a postdoctoral fellow with the Department of Orthopedics and Rehabilitation at Pennsylvania State College of Medicine, she gained vast expertise in design, development, and characterization of orthopaedic biomaterials (bone grafts) and translational research models (osseointegrated implants, mechanical loading of implants). Dr. Jariwala received the prestigious Entrepreneur Fellowship at The Center for the Translation of Rehabilitation Engineering Advances and Technology (TREAT), offered jointly by NIH and Dartmouth Biomedical Engineering Center (DBEC) for Orthopedics in 2016. Dr. Jariwala was the project lead for design, development, manufacturing, and non-clinical regulatory testing of an intra-osseous infusion needle placement guide (TibFinder^TM, Class I medical device) and also delivered expert consultation to accelerate commercialization of rehabilitation and assistive technologies, including guidance of FDA regulatory & reimbursement strategies for new medical devices.